Carboplatin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Carboplatin and local guidelines before prescribing.
Platinum cytotoxic
Mechanism
Platinum compound forming DNA crosslinks.
Uses
Ovarian, lung, head and neck, germ cell tumours.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Myelosuppression (thrombocytopenia), nausea, nephrotoxicity less than cisplatin.
Interactions
Aminoglycosides raise nephro- and ototoxicity risk.
Contraindications and cautions
Severe marrow suppression, severe renal impairment
Monitoring
FBC, U&E
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Dose by GFR
Overdose and reversal
Supportive
Special advice
Dose by renal function (Calvert formula); FBC before each cycle.
More from the textbook: uses, cautions and other points
- Platinum chemotherapy (cisplatin, carboplatin) | With pemetrexed (non-squamous NSCLC, mesothelioma) or etoposide (SCLC). Nausea, myelosuppression, neuropathy, nephrotoxicity (cisplatin).
Respiratory: Lung Cancer - How it works: Chemotherapy kills rapidly dividing cells, which is why it also affects the bone marrow, gut lining, hair follicles and gonads . It is given in cycles (e.g. every 2–3 weeks) to allow normal tissues to recover. Doses are based on body surface area (carboplatin on kidney function).
Oncology: Principles - Platinum drugs | Cisplatin - kidney damage , hearing loss , neuropathy , severe nausea, low magnesium (needs IV hydration). Carboplatin - marrow suppression (especially platelets). Oxaliplatin - cold-induced tingling and neuropathy
Oncology: Principles - Common with: Taxanes, platinums (especially carboplatin after several cycles), rituximab, daratumumab and other antibodies.
Oncology: Emergencies - Seminoma - very sensitive to radiotherapy and chemotherapy. Stage I: surveillance or one dose of carboplatin.
Oncology: Urology and Genital cancers - Carboplatin (single dose) | Stage I seminoma.
Oncology: Urology and Genital cancers - Chemotherapy - carboplatin with paclitaxel (6 cycles), either after surgery or before and after it (neoadjuvant, for extensive disease).
Oncology: Breast and Gynae Cancers - Carboplatin and paclitaxel with immunotherapy (dostarlimab or pembrolizumab - especially MMR-deficient).
Oncology: Breast and Gynae Cancers
Where it is discussed in the book
- Respiratory: Lung Cancer (1 mention)
- Oncology: Principles (2 mentions)
- Oncology: Emergencies (1 mention)
- Oncology: Urology and Genital cancers (2 mentions)
- Oncology: Breast and Gynae Cancers (4 mentions)
- Oncology: Skin Cancer (1 mention)
- ENT Anatomy Physiology (1 mention)
- ENT: Common Ear disorders (1 mention)
- Surgey: Urology (1 mention)
- Integrated respiratory chapter (1 mention)